FDA: Ziprasidone can cause rare, serious adverse drug reaction

FDA: ziprasidone can cause rare, serious adverse drug reaction

(HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food and Drug Administration says.

The agency has ordered that ziprasidone's label carry a new warning about this condition, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

Patients who are taking ziprasidone and develop a fever with a rash and/or swollen lymph glands should seek immediate medical care. If DRESS is suspected, doctors should immediately take patients off the drug, the FDA said. DRESS can lead to inflammation of the liver, kidney, lungs, heart, or pancreas, and possibly death.

"We urge and patients to report side effects involving ziprasidone to the FDA MedWatch program," the FDA said in a safety alert.

Explore further

FDA approves generic version of celebrex

More information: More Information

Copyright © 2014 HealthDay. All rights reserved.

Citation: FDA: Ziprasidone can cause rare, serious adverse drug reaction (2014, December 14) retrieved 16 June 2021 from https://medicalxpress.com/news/2014-12-fda-ziprasidone-rare-adverse-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments